Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Preclinical investigation of anti-CEA antibody fragments as tumor imaging probes: Comparison of biodistribution and pharmacokinetics

Erwan Jouannot, Sébastien d'Heilly and Chantal Carrez
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1334;
Erwan Jouannot
1Sanofi Oncology, Sanofi, Vitry sur Seine, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sébastien d'Heilly
1Sanofi Oncology, Sanofi, Vitry sur Seine, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal Carrez
1Sanofi Oncology, Sanofi, Vitry sur Seine, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 1334

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Erwan Jouannot1,
  2. Sébastien d'Heilly1 and
  3. Chantal Carrez1
  1. 1Sanofi Oncology, Sanofi, Vitry sur Seine, France

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014200
Jan 2015200
Feb 2015100
Jun 2015100
Sep 2015600
Dec 2015600
Jan 2016200
Mar 2016300
Apr 2016100
May 2016100
Jul 2016300
Sep 2016200
Oct 2016300
Nov 2016200
Dec 2016500
Jan 2017600
Feb 2017600
Mar 2017200
May 2017300
Jun 2017300
Jul 2017400
Aug 2017600
Sep 2017400
Oct 2017600
Nov 2017400
Dec 20171000
Jan 2018700
Feb 2018800
Mar 2018500
Apr 2018400
May 20181400
Jun 20181400
Jul 20181000
Aug 2018500
Sep 2018400
Oct 20181000
Nov 2018600
Dec 20181400
Jan 20191100
Feb 20192000
Mar 20191000
Apr 20191400
May 2019100
Jun 2019500
Jul 20191100
Aug 2019600
Sep 2019200
Dec 2019100
Feb 2020100
Mar 2020300
Apr 2020100
May 2020300
Jun 2020100
Jul 2020200
Aug 2020400
Nov 2020100
Dec 2020200
Jan 2021100
Feb 20211500
Mar 20211000
Apr 20212200
May 20211400
Jun 2021400
Jul 2021400
Aug 2021400
Sep 2021400
Oct 2021400
Nov 2021600
Dec 2021600
Jan 2022200
Feb 2022200
Mar 2022200
Apr 2022200
May 2022200
Jun 2022200
Jul 2022100
Aug 2022200
Sep 2022300
Dec 2022100
Jan 2023100
Mar 2023800
Apr 2023200
May 2023300
Jun 2023200
Jul 2023200
Aug 2023200
Sep 2023500
Oct 2023100
Nov 2023300
Dec 2023400
Jan 2024500
Mar 2024300
Apr 2024200
May 2024300
Jun 2024200
Jul 20245000
Aug 20244000
Sep 20241900
Oct 2024500
Nov 2024200
Dec 2024600
Jan 2025200
Feb 2025300
Mar 2025200
Apr 2025600
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical investigation of anti-CEA antibody fragments as tumor imaging probes: Comparison of biodistribution and pharmacokinetics
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preclinical investigation of anti-CEA antibody fragments as tumor imaging probes: Comparison of biodistribution and pharmacokinetics
Erwan Jouannot, Sébastien d'Heilly, Chantal Carrez
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1334;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preclinical investigation of anti-CEA antibody fragments as tumor imaging probes: Comparison of biodistribution and pharmacokinetics
Erwan Jouannot, Sébastien d'Heilly, Chantal Carrez
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1334;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • The frequency and content of documentation for patients’ 131I therapies for checkpoint security agents: the final report of a national survey.
  • Radiopeptide Therapy using Lu-177 3BP-227 in a Patient with Pancreatic Adenocarcinoma
  • Comparing two methods for 90Y PET based dosimetry as a predictor of metabolic response for patients receiving radioembolisation
Show more Oncology: Basic, Translational & Therapy

MTA I: Basic Science (Oncology) Posters

  • Evaluation of the effect of microRNA on hepatocellular carcinoma proliferation and metastasis by FDG small-animal PET
  • Targeting cancer stem cells with 131I-labeled anti-AC133.1 monoclonal antibody on human colorectal cancer xenografts
  • Assessment of 18F-FLT PET to predict treatment response in HER2+ breast cancer xenografts
Show more MTA I: Basic Science (Oncology) Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire